May we target double‐membrane vesicles and oxysterol‐binding protein to combat SARS‐CoV‐2 infection?

Ähnliche Einträge

• Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
  von: Habtemariam, Solomon, et al.
  Veröffentlicht: (2020)
• Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
  von: Dowran, Razieh, et al.
  Veröffentlicht: (2020)
• Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
  von: Nabavi, Seyed Fazel, et al.
  Veröffentlicht: (2020)
• Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
  von: Nabavi, Seyed Fazel, et al.
  Veröffentlicht: (2020)
• Should we try the antiinflammatory natural product, celastrol, for COVID‐19?
  von: Habtemariam, Solomon, et al.
  Veröffentlicht: (2020)